Harrow (HROW) Accounts Payables (2010 - 2026)
Harrow's (HROW) quarterly Accounts Payables came in at $30.0 million in Q1 2026, down 19.08% year-on-year from $37.1 million in Q1 2025, and down 15.1% quarter-over-quarter from $35.4 million in Q4 2025.
Harrow (HROW) Accounts Payables (2010 - 2026) Analysis & Trends
Harrow's Accounts Payables history runs 17 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- On a quarterly basis, Accounts Payables fell 19.08% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $30.0 million, a 19.08% decrease from a year earlier, with the FY2025 full-year figure at $35.4 million, down 8.79% from the prior year.
- Accounts Payables fell to $30.0 million in Q1 2026 per HROW's latest filing, from $35.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $38.8 million in Q4 2024 and bottomed at $6.8 million in Q1 2022.
- The 5-year median for Accounts Payables is $20.2 million (2025), against an average of $21.3 million.
- Biggest YoY gain for Accounts Payables was 145.19% in 2025; the steepest drop was 20.24% in 2025.
- Year by year, Accounts Payables stood at $13.8 million in 2022, then jumped by 78.5% to $24.6 million in 2023, then soared by 57.69% to $38.8 million in 2024, then decreased by 8.79% to $35.4 million in 2025, then decreased by 15.1% to $30.0 million in 2026.
- Per Business Quant, the three latest HROW Accounts Payables figures stand at $30.0 million (Q1 2026), $35.4 million (Q4 2025), and $20.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 30.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.02 Mn |
| Dec 31, 2025 | 35.36 Mn |
| Sep 30, 2025 | 20.16 Mn |
| Jun 30, 2025 | 25.41 Mn |
| Mar 31, 2025 | 37.10 Mn |
| Dec 31, 2024 | 38.76 Mn |
| Sep 30, 2024 | 25.28 Mn |
| Jun 30, 2024 | 22.26 Mn |
| Mar 31, 2024 | 15.13 Mn |
| Dec 31, 2023 | 24.58 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 17.82 Mn |
| Mar 31, 2023 | 13.79 Mn |
| Dec 31, 2022 | 13.77 Mn |
| Sep 30, 2022 | 14.11 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 6.76 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 7.34 Mn |
| Jun 30, 2021 | 5.21 Mn |